What ASMS 2026 Is Signaling About the Future of Biologics Development
Three Emerging Trends From San Diego Worth Watching KBI Biopharma | June 2026 Select researchers from the KBI Biopharma...
Webinars
BIOSECURE, Tariffs, and the New CDMO Reality for Biopharma Innovators
For biopharma innovators, manufacturing strategy is no longer just a CMC decision. It is becoming a question that...
Beyond the Count: Why Particle Forensics Matters More Than Ever in Biologics Development
By Marissa Jones, PhD | March 2026 "We don't want to gamble with the success of our program, and we don't want to...